DT

Doug Treco

CEO and Chairman

Inozyme Pharma

Arlington, Massachusetts


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Inozyme Pharma
Industry
research
Employees
68.0
Seniority
C suite
Annual Revenue
76000.0

Technologies

Amazon SES Mimecast Outlook Microsoft Office 365 WP Engine Webflow Salesforce Adobe Marketing Cloud Data Analytics Basis Remote AI

Keywords

biotechnology: pharmaceutical preparations health care biotechnology research enpp1 deficiency abcc6 deficiency calciphylaxis inz-701 enzyme replacement therapy clinical trials rare diseases ppi-adenosine pathway investigational therapy genetic testing patient registry expanded access mineralization disorders biopharmaceutical healthcare professionals patient education comprehensive support innovative therapeutics phosphate regulation bone health vascular health adenosine regulation patient outcomes medical research community support disease management calcium phosphate clinical development safety & tolerability efficacy assessments medical conditions clinical data therapeutic options healthcare equity personalized healing rare genetic disorders disease progression investor relations scientific research healthcare innovation biotechnology patient testimonies evidence-based approach longitudinal studies healthcare collaboration disease characterization scientific publishing clinical efficacy preventive treatment specialized therapies health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans